Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
5,173
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis

Cathrine Dawn Büttner Elgaarda Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark;b Danish National Center for Autoimmune Diseases, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0003-1965-4242
ORCID Icon,
Lars Iversena Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark;b Danish National Center for Autoimmune Diseases, Aarhus University Hospital, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0003-1816-4508
ORCID Icon &
Kasper Fjellhaugen Hjulera Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark;b Danish National Center for Autoimmune Diseases, Aarhus University Hospital, Aarhus, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6082-5096
ORCID Icon
Article: 2133531 | Received 22 Jul 2022, Accepted 30 Sep 2022, Published online: 18 Oct 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lluís Rusiñol, Elena Carmona-Rocha & Lluís Puig. (2023) Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology 0:0, pages 1-12.
Read now

Articles from other publishers (3)

Aristeidis G. Vaiopoulos, Maria Dalamaga, Pelagia Katsimbri, Marios Koumourtzis, Kyriaki Lampadaki, Konstantinos Theodoropoulos, Sofia Theotokoglou, Antonios Kanelleas, Anna Syrmali, Alexandra Filippopoulou, Konstantina Zoupidou, Alexander Katoulis & Evangelia Papadavid. (2023) Real‐world data show high efficacy of IL23 inhibitors guselkumab and risankizumab in psoriatic arthritis and difficult‐to‐treat areas . International Journal of Dermatology 62:11, pages 1404-1413.
Crossref
Fabrizio Calapai, Carmen Mannucci, Luigi Cardia, Mariaconcetta Currò, Gioacchino Calapai, Emanuela Esposito & Ilaria Ammendolia. (2023) Suspected oncologic adverse reactions associated with interleukin‐23 inhibitors in EudraVigilance : Comparative study and gender distribution . Pharmacology Research & Perspectives 11:5.
Crossref
Tumay Ak, Sera Nur Yucesoy Temiz, Meliksah Taner, Ali Yagiz Ayla, Ahmet Atıl Aygun, Burhan Engin, Gunay Can & Serdal Ugurlu. (2023) Effectiveness of anti‐interleukin ‐23 therapy in psoriatic arthritis: A pilot prospective real‐world study . International Journal of Rheumatic Diseases 26:5, pages 878-884.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.